The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Therapeutic lymphangiogenesis with human recombinant VEGF‐C
Abstract
Chronic regional impairments of the lymphatic circulation often lead to striking architectural abnormalities in the lymphedematous tissues. Lymphedema is a common, disabling disease that currently lacks a cure. Vascular endothelial growth factors C and D mediate lymphangiogenesis through the VEGFR‐3 receptor on lymphatic endothelia. The purpose of this study was to investigate the therapeutic potential for lymphangiogenesis with VEGF‐C. We developed a rabbit ear model to simulate human chronic postsurgical lymphatic insufficiency. Successful, sustained surgical ablation of the ear lymphatics was confirmed by water displacement volumetry. After complete healing, the experimental animals (n=8) received a single, s.c. 100 μg dose of VEGF‐C in the operated ear; controls (n=8) received normal saline. Radionuclide lymphoscintigraphy was performed to quantitate lymphatic function. Immunohistochemistry (IHC) was performed 7–8 days following treatment. After VEGF‐C, there was a quantifiable amelioration of lymphatic function. IHC confirmed a significant increase in lymphatic vascularity, along with reversal of the intense tissue hypercellularity of untreated lymphedema. This study confirms the capacity of a single dose of VEGF‐C to induce therapeutic lymphangiogenesis in acquired lymphedema. In addition to improving lymphatic function and vascularity, VEGF‐C can apparently reverse the abnormalities in tissue architecture that accompany chronic lymphatic insufficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Self-citationJoukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Self-citationKaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Self-citationHyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Self-citationBaumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.12.1114 · Cited by 1,098
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004 · cited 1×
“Therapeutic lymphangiogenesis may hold significant promise for lymphatic vascular insufficiency (34), in analogy to the proposed treatment strategies for circulatory insufficiency of the myocardium and other major vascular beds (35, 36).”
BackgroundSelf-citationCardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Self-citationRegulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola, T., Karkkainen, M. J., Claesson, L., & Alitalo, K. K. (2000) · PubMed · Cited by 864
Self-citationGale, N. W., & Yancopoulos, G. D. (1999) · Genes & Development · doi:10.1101/gad.13.9.1055 · Cited by 784
Proteolytic processing regulates receptor specificity and activity of VEGF-C
Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N., & Alitalo, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3898 · Cited by 773
Self-citationVeikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T. V., Kubo, H., Thurston, G., McDonald, D. M., Achen, M. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1223 · Cited by 663
Self-citationMissense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Self-citationA model for gene therapy of human hereditary lymphedema
Karkkainen, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221449198 · Cited by 606
Self-citationOh, S.-J., Jeltsch, M. M., Birkenhäger, R., McCarthy, J. E. G., Weich, H. A., Christ, B., Alitalo, K., & Wilting, J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8639 · Cited by 498
Self-citationRockson, S. G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00727-0 · Cited by 474
Self-citationIncidence of breast carcinoma-related lymphedema
Petrek, J. A., & Heelan, M. C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+<2776::aid-cncr25>3.0.co;2-v · Cited by 462
Lymphedema: classification, diagnosis and therapy
Szuba, A., & Rockson, S. G. (1998) · Vascular Medicine · doi:10.1177/1358836x9800300209 · Cited by 446
Self-citationJoukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00521.x · Cited by 423
Self-citationLee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., & Wood, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1988 · Cited by 401
Partanen, T. A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S. A., Achen, M. G., & Alitalo, K. (2000) · The FASEB Journal · doi:10.1096/fj.99-1049com · Cited by 346
Self-citationCurrent Therapy in Vascular Surgery
Gewertz, B. L. (1988) · Annals of Vascular Surgery · doi:10.1016/s0890-5096(06)60828-5 · Cited by 279
Structure, Function, and Molecular Control of the Skin Lymphatic System
Skobe, M., & Detmar, M. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00001.x · Cited by 257
Self-citationMonoclonal antibody PAL-E specific for endothelium.
Schlingemann, R. O., Dingjan, G. M., Emeis, J. J., Blok, J., Warnaar, S. O., & Ruiter, D. J. (1985) · PubMed · Cited by 251
The pathophysiology of lymphedema
Mortimer, P. S. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+<2798::aid-cncr28>3.3.co;2-5 · Cited by 239
Kaulesar Sukul, D. M. K. S., den Hoed, P. T., Johannes, E. J., van Dolder, R., & Benda, E. (1993) · Journal of Biomedical Engineering · doi:10.1016/0141-5425(93)90062-4 · Cited by 225
SAARISTO, A., VEIKKOLA, T., ENHOLM, B., HYTÖNEN, M., AROLA, J., PAJUSOLA, K., TURUNEN, P., JELTSCH, M., KARKKAINEN, M. J., KERJASCHKI, D., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-1042com · Cited by 177
Self-citationFactors that Influence the Incidence of Brachial Oedema After Treatment of Breast Cancer
Segerström, K., Bjerle, P., Graffman, S., & Nyström, Å. (1992) · Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery · doi:10.3109/02844319209016016 · Cited by 173
Workgroup III: Diagnosis and management of lymphedema
Rockson, S. G., Miller, L. T., Senie, R., Brennan, M. J., Casley-Smith, J. R., F�ldi, E., F�ldi, M., Gamble, G. L., Kasseroller, R. G., Leduc, A., et al. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+<2882::aid-cncr45>3.0.co;2-0 · Cited by 160
Self-citationA review of measures of lymphedema
Gerber, L. H. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+<2803::aid-cncr29>3.0.co;2-w · Cited by 124
Szuba, A., Strauss, W. H., SIRSIKAR, S. P., & Rockson, S. G. (2002) · Nuclear Medicine Communications · doi:10.1097/00006231-200212000-00004 · Cited by 108
Self-citationIdiopathic Lymphedema: Review of 131 Cases
SCHIRGER, A., HARRISON, E. G., & JANES, J. M. (1962) · JAMA · doi:10.1001/jama.1962.03050400016004 · Cited by 83
Imaging techniques in the management and prevention of posttherapeutic upper limb edemas
Bourgeois, P., Leduc, O., & Leduc, A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+<2805::aid-cncr30>3.3.co;2-6 · Cited by 61
Darózy, J. (1995) · Clinics in Dermatology · doi:10.1016/0738-081x(95)00086-u · Cited by 61
Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease
Rivard, A., & Isner, J. M. (1998) · Molecular Medicine · doi:10.1007/bf03401749 · Cited by 60
Angiogenesis in wound healing and tumor metastasis.
Ruiter, D. J., Schlingemann, R. O., Westphal, J. R., Denijn, M., Rietveld, F. J. R., & Waal, R. M. W. D. (1993) · PubMed · Cited by 56
Experimental lymphedema in dogs.
Olszewski, W. L., Machowski, Z., Sokołowski, J., & Nielubowicz, J. (1968) · PubMed · Cited by 36
[Treatment of postoperative lymphedema of the upper limb].
Pecking, A. P. (1991) · PubMed · Cited by 7
Cited by
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
Rafii, S., & Lyden, D. (2003) · Nature Medicine · doi:10.1038/nm0603-702 · Cited by 1,577
The lymphatic vasculature in disease
Alitalo, K. (2011) · Nature Medicine · doi:10.1038/nm.2545 · Cited by 962
Self-citationTumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583
Cardiac lymphatics are heterogeneous in origin and respond to injury
Klotz, L., Norman, S., Vieira, J. M., Masters, M., Rohling, M., Dubé, K. N., Bollini, S., Matsuzaki, F., Carr, C. A., & Riley, P. R. (2015) · Nature · doi:10.1038/nature14483 · Cited by 506
Lymphatic vasculature development
Oliver, G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1258 · Cited by 461
Metadata
- Authors
- Szuba, A., Skobe, M., Karkkainen, M. J., Shin, W. S., Beynet, D. P., Rockson, N. B., Dakhil, N., Spilman, S., Goris, M. L., Strauss, H. W., Quertermous, T., Alitalo, K., & Rockson, S. G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-10-18
- Volume
- 16
- Issue
- 14
- Pages
- 1985-1987
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2137100240
- Cited by
- 260
- References
- 37
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.